INCIDENCE, SOCIODEMOGRAPHIC, AND CLINICAL CHARACTERISTICS OF ANOVULATORY INFERTILITY AMONG WOMEN PRESENTING TO A SECONDARY CARE HOSPITAL OF NORTH INDIA

ACHALA RAWAT; KRISHNA MUKHERRJEE; SHUBHA PANDEY

doi:10.22159/ajpcr.2024v17i10.52615

Authors

ACHALA RAWAT Department of Obstetrics and Gynecology, IMS BHU, Varanasi, Uttar Pradesh, India
KRISHNA MUKHERRJEE Department of Obstetrics and Gynecology, MLN Medical College, Prayagraj, Uttar Pradesh, India.
SHUBHA PANDEY Department of Obstetrics and Gynecology, Kamla Nehru Hospital, Prayagraj, Uttar Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2024v17i10.52615

Keywords:

nfertility, Polycystic ovarian syndrome, Hyperprolactinemia, Hypothyroidism, Anovulation

Abstract

Objectives: The objective of the study was to assess the incidence and factors associated with anovulatory infertility among reproductive-age women.

Methods: The study was an observational cross-sectional study conducted in the Department of Obstetrics and Gynecology of a secondary care hospital of Prayagraj, Uttar Pradesh over a period of 20 months, from October 2020 to May 2022. A consecutive sampling method was used to recruit a total of 100 women presenting with a complaint of inability to conceive even after regular intercourse over the past 1 year into the present research. Based on the detailed physical and clinical examination as well as laboratory findings, the final diagnosis of the cause and the nature of the infertility (primary/secondary) were established.

Results: Among the 100 patients, 22 were found to have anovulatory infertility. The mean age was 28.68±3.71 years. Majority (50%) belonged to the upper socioeconomic class the mean weight of patients was 55.91±5.66 kg and the mean body mass index was 22.85±2.21 kg/m2. Majority presented with normal menstruation, followed by oligomenorrhoea (45.5%). 81.8% of the participants had hirsutism. The mean follicle-stimulating hormone of patients was 6.30±1.87 IU/mL, the mean luteinizing hormone was 6.04±1.83 IU/mL, mean estradiol was 45.00±6.50 pg/mL, mean anti-mullerian hormone was 6.94±2.13 ng/mL, mean total cholesterol was 76.21±16.86 ng/dL, mean thyroid stimulating hormone was 2.63±0.98 mIU/L and mean prolactin was 15.94±4.94 ng/mL. About 86.4% had primary infertility, the most common cause being polycystic ovarian syndrome (PCOS, 63.6%). This was followed by hyperprolactinemia (13.6%) and hypothyroidism (9.2%). Secondary anovulation associated with obesity was identified in 13.6% of the patients.

Conclusion: The incidence of anovulatory infertility was 22%, with the majority being primary infertility due to PCOS, followed by hyperprolactinemia, and hypothyroidism.

Downloads

Download data is not yet available.

References

Petraglia F, Serour GI, Chapron C. The changing prevalence of infertility. Int J Gynecol Obstet. 2013;123:S4-8.

Chandra A, Copen CE, Stephen EH. Infertility service use in the United States: Data from the National Survey of Family Growth, 1982-2010. Natl Health Stat Report. 2014;73:1-21.

Oakley L, Doyle P, Maconochie N. Lifetime prevalence of infertility and infertility treatment in the UK: Results from a population-based survey of reproduction. Hum Reprod. 2008;23(2):447-50.

Bushnik T, Cook JL, Yuzpe AA, Tough S, Collins J. Estimating the prevalence of infertility in Canada. Hum Reprod. 2012;27(3):738-46.

Sanad ZF, Kalil NA, Beddah ES. Infertility and related risk factors among women attending rural family health facilities in Menoufia Governorate. Menoufia Med J. 2019;32(4):1365.

McLaren JF. Infertility evaluation. Obstet Gynecol Clin North Am. 2012;39(4):453-63.

Li RH, Ng EH. Management of anovulatory infertility. Best Pract Res Clin Obstet Gynaecol. 2012;26(6):757-68.

Van der Spuy ZM, Dyer SJ. The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):755-71.

Bhandoria G, Rudra S. Anovulatory infertility: A prospective study. Int J Infertil Fetal Med. 2013;4(1):18-23.

Singangutti R. Incidence and etiologic factors responsible for anovulation in infertility cases. Int J Reprod Contracept Obstet Gynecol. 2018;7(4):1568.

Bhoyar R, Rathi S, Mishra S, Kotpalliwar S. Screening for thyroid disorders in infertile women. Int J Clin Obstet Gynaecol. 2020;4(2):209- 11.

Fitzgerald C, Zimon AE, Jones EE. Aging and reproductive potential in women. Yale J Biol Med. 1998;71(5):367.

Ali MM, Ghazi W, Abboud AH. Prevalence of anovulation in subfertile women in Kerbala 2012, a descriptive cross-sectional study. Al-Kufa Univ J Biol. 2014;6(2):1-6.

Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. J Cardiovasc Dis Res. 2012;3(3):204-11.

Mohan V, Shanthirani S, Deepa R, Premalatha G, Sastry NG, Saroja R. Intra‐urban differences in the prevalence of the metabolic syndrome in southern India-the Chennai Urban Population Study (CUPS No. 4). Diabet Med. 2001;18(4):280-7.

Sudha G, Reddy KS. Causes of female infertility: A crosssectional study. Int J Latest Res Sci Technol. 2013;2(6):119-23.

Fichman V, Costa RD, Miglioli TC, Marinheiro LP. Association of obesity and anovulatory infertility. Einstein (Sao Paulo). 2020;18:eAO5150.

Khan A, Karim N, Ainuddin JA, Fahim MF. Polycystic ovarian syndrome: Correlation between clinical hyperandrogenism, anthropometric, metabolic and endocrine parameters. Pak J Med Sci. 2019;35(5):1227-32.

Elhussein OG, Ahmed MA, Suliman SO, Adam I. Epidemiology of infertility and characteristics of infertile couples requesting assisted reproduction in a low-resource setting in Africa, Sudan. Fertil Res Pract. 2019;5(1):7.

Gupta S, Goldberg JM, Aziz N, Goldberg E, Krajcir N, Agarwal A. Pathogenic mechanisms in endometriosis-associated infertility. Fertil Steril. 2008;90(2):247-57.

Pajai S, Potdar J, Gopal U, Banait T, Gopal KU. A review on the use of letrozole in female and male infertility. Cureus. 2022;14(11):e31291.